| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Eric Affeldt is Director at SRTA, with reported holdings spanning 2 companies. Eric Affeldt's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $801K at current prices.
Eric Affeldt's largest disclosed position is in SRTA as Director, worth about $737K. Net of sales, the SRTA filings show accumulation of 60,000 shares.
Eric Affeldt has 12 Form 4 filings on record from May 2021 to September 2026, across 2 companies: Director at Aiai (AIAI), 2026; Director at Strata Critical Medical (SRTA), 2021–2025.
The 13 reported transactions were 5 stock awards, 4 open-market purchases, 2 gifts and 2 other transactions.
Counted by filing, the open-market trades come to 4 purchases worth about $434K and no sales.
The largest open-market purchase was 50,000 shares of SRTA at an average $3.20 on November 13, 2023, about $160K. Twelve months later SRTA was up 6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | AIAI Aiai Holdings Corporation | Director | Buy | 42,857 | $3.50 | $149,999.50 | +857.1% | - | - | |
| Aug 19, 2026 | AIAI Aiai Holdings Corporation | Director | Buy | 5,000 | $5.96 | $29,800.00 | New | - | - | |
| Nov 13, 2023 | SRTA Strata Critical Medical, Inc. | Director | Buy | 50,000 | $3.20 | $159,840.00 | +500.0% | -2.1% | +6.4% | |
| May 27, 2021 | SRTA Strata Critical Medical, Inc. | Director | Buy | 10,000 | $9.42 | $94,200.00 | New | -18.0% | -25.3% |